Jamjoom Pharmaceuticals Factory Company announces obtaining approval from Saudi Food and Drug Authority (SFDA) to register its new Sterile Facility (ophthalmic products) in Jeddah
| Element List | Explanation |
|---|---|
| Announcement Detail | Jamjoom Pharmaceuticals Factory Company is pleased to announce the issuance of the Saudi Food and Drug Authority’s (SFDA) approval to register the new Sterile Facility (ophthalmic products) in Jeddah.
The state-of-the-art facility is built on an area of 7,500 sqm in phase 5 of the Jeddah Industrial District, and costs approximately SAR 200 million in construction The facility specializes in producing sterile products (ophthalmic products), and its annual production capacity will reach 25 million units at full operations.
Commercial production at this facility will commence once the relevant products approvals have been obtained from the SFDA.
In case of any inquiries, please feel free to contact the Investor Relations department via email: |
Comments